These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11697498)

  • 1. Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma.
    Avigdor A; Raanani P; Levi I; Hardan I; Ben-Bassat I
    Leuk Lymphoma; 2001 Aug; 42(4):683-7. PubMed ID: 11697498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic plasmacytosis as a manifestation of relapse in multiple myeloma treated with thalidomide.
    del Giglio A; Weinschenker P; Manhani AR; Carbonell AL; Mitteldorf CA
    South Med J; 2005 Feb; 98(2):238-40. PubMed ID: 15759959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide in multiple myeloma: lack of response of soft-tissue plasmacytomas.
    Bladé J; Perales M; Rosiñol L; Tuset M; Montoto S; Esteve J; Cobo F; Villela L; Rafel M; Nomdedeu B; Montserrat E
    Br J Haematol; 2001 May; 113(2):422-4. PubMed ID: 11380408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extramedullary multiple myeloma escapes the effect of thalidomide.
    Rosiñol L; Cibeira MT; Bladé J; Esteve J; Aymerich M; Rozman M; Segarra M; Cid MC; Filella X; Montserrat E
    Haematologica; 2004 Jul; 89(7):832-6. PubMed ID: 15257935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between intracranial plasmacytoma and multiple myeloma: clinicopathological outcome study.
    Schwartz TH; Rhiew R; Isaacson SR; Orazi A; Bruce JN
    Neurosurgery; 2001 Nov; 49(5):1039-44; discussion 1044-5. PubMed ID: 11846895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant response or progression in patients with myeloma treated with thalidomide-based regimens.
    Anagnostopoulos A; Hamilos G; Zorzou MP; Grigoraki V; Anagnostou D; Dimopoulos MA
    Leuk Lymphoma; 2004 Jan; 45(1):113-6. PubMed ID: 15061206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of extramedullary plasmablastic plasmacytoma successfully treated using a combination of thalidomide and dexamethasone and a review of the medical literature.
    Sekiguchi Y; Asahina T; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Komatsu N; Noguchi M
    J Clin Exp Hematop; 2013; 53(1):21-8. PubMed ID: 23801130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.
    Terpos E; Rezvani K; Basu S; Milne AE; Rose PE; Scott GL; Rahemtulla A; Samson D; Apperley JF
    Eur J Haematol; 2005 Nov; 75(5):376-83. PubMed ID: 16191086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasmocytoma in the nasal cavity and paranasal sinuses].
    Bień S; Kobiorska-Nowak J
    Otolaryngol Pol; 2009; 63(3):287-92. PubMed ID: 19886539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical analysis of 25 cases of multiple myeloma complicated by extramedullary plasmacytomas].
    Zhong YP; Chen SL
    Zhonghua Nei Ke Za Zhi; 2009 May; 48(5):396-8. PubMed ID: 19615158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?
    Marchica V; Accardi F; Storti P; Mancini C; Martella E; Dalla Palma B; Bolzoni M; Todoerti K; Marcatti M; Schifano C; Bonomini S; Sammarelli G; Neri A; Ponzoni M; Aversa F; Giuliani N
    Int J Hematol; 2017 Jan; 105(1):104-108. PubMed ID: 27699576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive myeloma after thalidomide therapy in a patient with immature phenotype of myeloma (plasma) cells.
    Okikawa Y; Sakai A; Takimoto Y; Noda M; Imagawa J; Katayama Y; Kuroda Y; Okita H; Fujimura K; Kimura A
    Int J Hematol; 2004 May; 79(4):364-8. PubMed ID: 15218967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary extramedullary plasmacytoma with diffuse lymph node involvement: a case report and review of the literature.
    Naymagon L; Abdul-Hay M
    J Med Case Rep; 2019 May; 13(1):153. PubMed ID: 31113466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extramedullary Manifestation of Multiple Myeloma in the Oral Cavity.
    de Assis Pereira Hansen C; Filho JS; de Mattos Nascimento M; Alves FA; Neotti T; D Almeida Costa F
    Arch Iran Med; 2018 Dec; 21(12):611-612. PubMed ID: 30634861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.
    Bladé J; Fernández de Larrea C; Rosiñol L; Cibeira MT; Jiménez R; Powles R
    J Clin Oncol; 2011 Oct; 29(28):3805-12. PubMed ID: 21900099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent multiple myeloma presenting as a breast plasmacytoma.
    Kalyani A; Rohaizak M; Cheong SK; Nor Aini U; Balasundaram V; Norlia A
    Med J Malaysia; 2010 Sep; 65(3):227-8. PubMed ID: 21939175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile of multiple myeloma and effect of thalidomide based treatment on its outcome.
    Sridhar S; Dutta TK; Basu D
    J Indian Med Assoc; 2011 Dec; 109(12):880-2, 887-8. PubMed ID: 23469567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cranial nerve palsy in multiple myeloma and solitary plasmacytoma.
    Kashyap R; Kumar R; Kumar S
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):251-5. PubMed ID: 21114773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of thalidomide in refractory multiple myeloma.
    Singhal S; Mehta J; Desikan R; Ayers D; Roberson P; Eddlemon P; Munshi N; Anaissie E; Wilson C; Dhodapkar M; Zeddis J; Barlogie B
    N Engl J Med; 1999 Nov; 341(21):1565-71. PubMed ID: 10564685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.
    Cavo M; Tacchetti P; Patriarca F; Petrucci MT; Pantani L; Galli M; Di Raimondo F; Crippa C; Zamagni E; Palumbo A; Offidani M; Corradini P; Narni F; Spadano A; Pescosta N; Deliliers GL; Ledda A; Cellini C; Caravita T; Tosi P; Baccarani M;
    Lancet; 2010 Dec; 376(9758):2075-85. PubMed ID: 21146205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.